Pluristem Financial Statements From 2010 to 2024
| PSTI Stock | ILS 1,786 40.00 2.19% |
Check Pluristem financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pluristem's main balance sheet or income statement drivers, such as , as well as many indicators such as . Pluristem financial statements analysis is a perfect complement when working with Pluristem Valuation or Volatility modules.
Pluristem |
Pluristem Company Return On Equity Analysis
Pluristem's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Pluristem Return On Equity | -0.87 |
Most of Pluristem's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Pluristem is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Pluristem has a Return On Equity of -0.8655. This is 96.39% lower than that of the Healthcare sector and 97.63% lower than that of the Biotechnology industry. The return on equity for all Israel stocks is 179.19% higher than that of the company.
Pluristem Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Pluristem's current stock value. Our valuation model uses many indicators to compare Pluristem value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Pluristem competition to find correlations between indicators driving Pluristem's intrinsic value. More Info.Pluristem is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Pluristem by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Pluristem's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Pluristem Financial Statements
Pluristem stakeholders use historical fundamental indicators, such as Pluristem's revenue or net income, to determine how well the company is positioned to perform in the future. Although Pluristem investors may analyze each financial statement separately, they are all interrelated. For example, changes in Pluristem's assets and liabilities are reflected in the revenues and expenses on Pluristem's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Pluristem. Please read more on our technical analysis and fundamental analysis pages.
Pluristem Therapeutics Inc., together with its subsidiary, Pluristem Ltd., operates as a bio-therapeutics company in Israel. Pluristem Therapeutics Inc. was founded in 2001 and is based in Haifa, Israel. PLURISTEM THERAPEU operates under Biotechnology classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 172 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Pluristem Stock
Pluristem financial ratios help investors to determine whether Pluristem Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Pluristem with respect to the benefits of owning Pluristem security.